BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2018
View Archived Issues
FDA clears IND application for a phase I study of OBI-888
Read More
Transgene begins phase I study of T-101 for HBV in China
Read More
Life Science Institute announces beginning of exploratory study of CL-2020
Read More
Sandoz enters biosimilar partnership with Biocon
Read More
Program to study radezolid for bacterial vaginosis begins
Read More
Pandion Therapeutics announces completion of series A financing
Read More
Evaluation of [18F]MK-6240 for tau pathology imaging shows promise
Read More
Japanese approval for Lynparza as maintenance therapy in advanced ovarian cancer
Read More
Inception 4 patents novel HTRA1 inhibitors
Read More
Orion divulges alpha2C adrenoceptor antagonists
Read More
Bristol-Myers Squibb identifies new TLR7/8/9 antagonists
Read More
Zhejiang Hisun Pharmaceutical presents new SERAMs for cancer
Read More
Pfizer's Besponsa approved in Japan for ALL
Read More
Novel mutant IDH1 inhibitors presented by HHS
Read More
OPC-64005 studied in phase II trial for utility in adult ADHD
Read More
Janssen initiates phase I trial of JNJ-63733657 in healthy subjects and those with Alzheimer's
Read More
Fucoidans tested in combination with chemotherapy in cancer models in vivo
Read More
Eisai licenses ex-Japan rights for E-7046 to Adlai Nortye
Read More
Elobixibat approved in Japan for chronic constipation
Read More
Rexulti tablets approved in Japan for schizophrenia
Read More
Tecentriq approved in Japan for advanced NSCLC
Read More
European Commission approves bevacizumab biosimilar Mvasi
Read More
OncoSec Medical reports preliminary data from biomarker study of ImmunoPulse IL-12
Read More
FDA awards rare pediatric disease designation to arimoclomol for Niemann-Pick disease Type C
Read More
Japanese authorities approve Sirturo for tuberculosis
Read More
Disruption of FUNDC1 function tied to heart failure
Read More
CXCR4, a therapeutic target for inhibiting ovarian cancer progression
Read More
Fasenra receives approval in Japan for bronchial asthma
Read More